1Uludskarya A,Chachaty E,Vantelon J M,et al.Surveillance of Aspergillus galactomannan antigenemia for invasive aspergillosis by enzyme-linked inmunosorbent assay in neutropenic patients treated for hematological malignancies[J].J Hematol 2000,1:111-116.
2Mennink-Kersten M A,Donnelly J P,Verweij P E.Detection of circulating galactomannan for the diagnosis and management of invasive aspergillosis[J].Lancet Infect Dis,2004,4:349 -357.
3Macrtens J,Verhaegen J,Lagrou K,et al.Screening for circulating galactomannan as noninvasive diagnostic patients and stem cell transplantation recipients:a prospective validation[J].Blood,2001,97:1604-1610.
4Rovira M,Jimenez M,De La Bellacasa J,et al.Detection of Aspergillus galactomannan by enzyme immunosorbent assay in recipients of allogeneic hematopoietic stem cell transplantation:a prospective study[J].Transplantation,2004,77:1260-1264.
5Pinel C,Fricker-Hidalgo H,Lebeau B,et al.Detection of circulating Aspergillus fumigatus galactomannan:value and limits of the Platelia test for diagnosing invasive aspergillosis[J].J Clin Microbiol,2003,41:2184-2186.
6Marr K A,Balajee S A,McLaughlin L,et al.Detection of galactomannan antigenemia by enzyme immunoassay for the diagnosis of invasive aspergillosis:variables that affect performance[J].J Infect Dis,2004,190:641-649.
7Sulahian A,Boutboul F,Ribaud P,et al.Value of antigen detection using and enzyme immunoassay in the diagnosis and prediction of invasive aspergillosis in two adults and pediatric hematology units during a 4-year prospective study[J].Cancer,2001,91:311-318.
8Maertens J,Theunissen K,Verbeken E,et al.Prospective clinical evaluation of lower cut-offs for galactomannan detection in adult neutropenic cancer patients and haematological stem cell transplant recipients[J].Br J Haematol,2004,126:852-860.
9Ostrosky-Zeichner L,Alexander B D,Kett D H,et al.Multicenter clinical evaluation of the (1 -3)-beta-D-glucan assay as an aid to diagnosis of fungal infections in humans[J].Clin Infect Dis,2005,41:654-659.
10Buchheidt D,Hummel M,Schleiermacher D,et al.Prospective clinical evaluation of a Light Cycler-mediated polymerase chain reaction assay,a nested-PCR assay,and a galactomannan enzyme-linked immunosorbent assay for detection of invasive aspergillosis in neutropenic cancer patients and haematological stem cell transplant recipients[J].Br J Haematol,2004,125:196-202.
6Chen TL, Chen HP, Fung CP, et al. Clinical characteristics, treatment and prognostic factors of candial meningitis in a teaching hospital in Taiwa. Scand J Infect Dis, 2004,36 ( 2 ) : 124-130.
7Gurses N, Kalayci AG. Fluconazole monotherapy for candidal meningitis in a premature infant. Clin Infect Dis, 1996,23 (3) : 645 -646.
8Hope WW, Smith PB, Arrieta A, et al. Population pharmacokineties of micafungin in neonates and young infants. Antimicrob Agents Chemother, 2010, 54 ( 6 ) : 2633-2637.
9Nakayama H, Shibuya K, Kimura M, wt al. Histopathological study of candidal infection in the central nervous system. Nippon Ishinkin Gakkai Zasshi, 2010, 51 ( 1 ) :31-45.
10Baradkar VP, Mathur M, Kumar S. Cerebral candida abscess in an infant. Indian J Med Microbiol, 2009, 27( 1 ) :70-72.
